Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11958902 Anti-TIGIT antibodies

Patent 11958902 was granted and assigned to Merck Sharp & Dohme Limited on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Merck Sharp & Dohme Limited

0

Current Assignee

Merck Sharp & Dohme Limited

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Linda Liang0

Wolfgang Seghezzi0

Laurence Fayadat-Dilman0

Veronica Juan0

Sybil M. G. Williams0

Date of Patent

April 16, 2024

0

Patent Application Number

169398830

Date Filed

July 27, 2020

0

Patent Citations

US Patent 8968750 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins

0

US Patent 7193069 Full-length cDNA

0

US Patent 7368527 HADDE71 polypeptides

0

US Patent 10766957 Anti-TIGIT antibodies

0

Patent Primary Examiner

0

CPC Code

0

0

Patent abstract

The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11958902 Anti-TIGIT antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool